MyCEI Login


Hepatitis C and Injection Drug Use


Published Date: 05/24/2022

Expiration Date: 12/14/2024

CE Credit: CME:1CNE: 1CPE: 1


This course will discuss the importance of treating HCV among people who inject drugs (PWID). It will highlight and describe why PWID are a priority population for enhancing HCV prevention, screening and linkage to care and treatment. It will review the epidemiology of HCV among PWID, HCV transmission and the role of injection drug use in transmission, the efficacy of current direct acting antivirals for this population and discuss innovative strategies and models of HCV care for PWID.


Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.


Anthony Martinez,MD, AAHIVS
Anthony Martinez, MD is Associate Professor of Medicine and Medical Director of Hepatology at the University at Buffalo. His interests are in development of novel treatment modalities for hepatitis C among people who use drugs. He has worked extensively in the field of addiction medicine and specializes in treating patients with hepatitis C and opiate dependency. Martinez is the director of the HCV mini-residency program funded by New York State at the University at Buffalo. A nationally and internationally recognized expert, he has been a principle investigator on numerous clinical trials and has been involved in the study of many novel agents for HCV specifically among drug users. He is a member of the American Association for the Study of Liver Disease where he was recently elected to the HCV special interest group steering committee, the European Association for the Study of The Liver and the American Society of Addiction Medicine

Learning Objectives

  • Review the epidemiology of HCV among people who inject drugs (PWID).
  • Describe HCV transmission among PWID and the role of injection drug use in HCV transmission.
  • Discuss the importance of treating PWID and available treatment regimens.
  • Summarize innovative strategies/models of HCV care for PWID.

Continuing Education Credit Information